GlaxoSmithKline plc (ADR) (NYSE:GSK)
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
nojpokey
(56.93)
Submitted: 2/26/2007 3:08:08 PM :
Start Price:
$43.68
GSK Score:
+4.78
Many drugs in the pipline especially in biological vaccinations. Adjuvant/viral combonations will improve the effectivity of the immunological response and decreace the ammount of antigen needed in the vaccine. (ie millions of vaccines rather then thousands can be produced with the same amount of antigen). search: GSK MPL
Recs
framinpl
(< 20)
Submitted: 2/14/2007 6:08:44 PM :
Start Price:
$44.51
GSK Score:
+3.23
With a loose 50% more weight pill, coming out before bathing suit season. I can't wait for it to come out.
Recs
andersriedel
(52.31)
Submitted: 2/12/2007 7:19:34 PM :
Start Price:
$43.60
GSK Score:
+4.04
10 % ownership of Genmab. probably one of the best things they've ever bought!
Recs
sonto
(42.19)
Submitted: 2/9/2007 9:04:52 PM :
Start Price:
$43.44
GSK Score:
+4.53
Just betting that the new diet drug approval means a nice bump to their bottom line.
Recs
alvinpall
(78.47)
Submitted: 2/9/2007 9:48:30 AM :
Start Price:
$43.06
GSK Score:
+6.23
Glaxo has at least two new products which shold be blockbusters. A weight loss pill approved for both otc and prescription as well as a cervical cancer vacine. Beside that the chart shows great risk but great promise. I like the company and think it will do very well. Better than expected earnings also help as do upgrades. There's much more to be said but I prefer to let the stock do the talking.
Recs
em5
(< 20)
Submitted: 2/8/2007 3:25:22 PM :
Start Price:
$42.55
GSK Score:
+7.37
I'm sorry i got on to this one at it's current price, i can only see it going further what with the pipeline they have. a sure fire long term investment!!!!
Recs
jcpalmer
(< 20)
Submitted: 2/1/2007 9:45:11 AM :
Start Price:
$41.73
GSK Score:
+8.91
Leader in vaccines.
Recs
user1290
(< 20)
Submitted: 1/23/2007 4:03:07 PM :
Start Price:
$42.08
GSK Score:
-7.15
Difficulties in the form of significant patent expirations on the horizon; pipeline has still yet to actually produce anything more than promise.
Recs
luckyman1980
(75.10)
Submitted: 1/22/2007 6:26:03 PM :
Start Price:
$42.14
GSK Score:
+6.53
Missed the upswing, but won't fall as fast as its American counterparts
Recs
apthatsme
(< 20)
Submitted: 1/21/2007 1:02:53 PM :
Start Price:
$42.48
GSK Score:
+6.24
great pipeline. vaccine business will be huge sales and earnings driver.
Recs
f6639630
(< 20)
Submitted: 1/20/2007 6:35:53 PM :
Start Price:
$42.48
GSK Score:
+6.24
Strong pipeline, nice dividend
Recs
Leftarmround
(< 20)
Submitted: 1/19/2007 6:07:30 PM :
Start Price:
$42.48
GSK Score:
-6.24
Too many big picture constrainsts in the big pharma industry. R
Recs
K2Vancouver
(95.31)
Submitted: 1/13/2007 11:29:42 PM :
Start Price:
$39.96
GSK Score:
+12.65
S&P 2007 Target $63, 4 stars
3% Div
Quote:
GSK's risk profile is limited by its broad and diversified product base its strong R&D pipeline.
Recs
lanoush
(69.80)
Submitted: 1/8/2007 2:50:30 PM :
Start Price:
$40.02
GSK Score:
+11.31
Company could be helped by Part D legislation. Also, its marketing of vaccines is likely to give it a boost in the future.
Recs
royopitz
(< 20)
Submitted: 1/3/2007 1:18:35 PM :
Start Price:
$41.06
GSK Score:
+9.60
Stock has been depressed due to lack of into regarding pipeline drugs.
Recs
Afthought
(31.36)
Submitted: 1/2/2007 6:06:10 PM :
Start Price:
$40.89
GSK Score:
+9.72
Roll of the dice.
Recs
OldNickel
(98.26)
Submitted: 12/28/2006 11:27:43 PM :
Start Price:
$40.06
GSK Score:
-11.82
The Democrats are coming! The Democrats are coming!
Recs
ihuggermugger
(73.28)
Submitted: 12/17/2006 11:50:02 PM :
Start Price:
$39.98
GSK Score:
+12.40
GSK just got a first-generation experimetal bird flu vaccine approval from Europe. If GSK is successful in the development of this vaccine, this could be huge.
Recs
biodetector
(31.46)
Submitted: 12/15/2006 12:23:10 PM :
Start Price:
$39.62
GSK Score:
+13.72
GSK has a wide range of pharmaceuticals on the market and in the pipeline. The stock price has been hit with the US election backlash, but is probably better insulated against pricing pressures than most. Also, while everyone has been thinking Tamaflu (Roche) for a potential influenza epidemic, GSK has Relenza which is at least as effective.
Recs
TMFJeffreyvan1
(95.50)
Submitted: 12/8/2006 8:00:44 PM :
Start Price:
$39.85
GSK Score:
+11.98
Strong healthcare company, new acquisition.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 181 - 200 of 221 : « Previous 5 6 7 8 9 10 11 12 Next »